MedPath

Supplementation With Vitamin D, Calcium or Both on Calcium Absorption and Bone Mineral Content in Children With JRA

Phase 3
Completed
Conditions
Juvenile Rheumatoid Arthritis
Interventions
Dietary Supplement: Cholecalciferol
Dietary Supplement: Calcium
Dietary Supplement: Calcium and cholecalciferol
Drug: Placebo
Registration Number
NCT00570934
Lead Sponsor
University of Missouri-Columbia
Brief Summary

2000 international units (IU) vitamin D, 1 gram (gm) calcium, or both given to children with Juvenile Rheumatoid Arthritis (JRA) may increase percent true calcium absorption, bone mineral turnover and/or bone mineralization.

Detailed Description

Supplementation With 2000 IU Vitamin D, 1 gm Calcium or Both on Calcium Absorption and Bone Mineralization in Children With Juvenile Rheumatoid Arthritis may increase percent true calcium absorption, bone mineral turnover and/or bone mineralization.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
24
Inclusion Criteria
  • Juvenile Rheumatoid arthritis
Exclusion Criteria
  • Steroid use

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
Calcium and cholecalciferolPlaceboorder of treatment calcium and cholecalciferol, cholecalciferol, calcium, placebo
CalciumCalcium and cholecalciferolorder of treatment calcium, placebo, calcium plus cholecalciferol, cholecalciferol
CholecalciferolCalciumorder of treatments cholecalciferol, calcium and Cholecalciferol, placebo, and calcium
CholecalciferolCalcium and cholecalciferolorder of treatments cholecalciferol, calcium and Cholecalciferol, placebo, and calcium
CalciumCholecalciferolorder of treatment calcium, placebo, calcium plus cholecalciferol, cholecalciferol
CholecalciferolCholecalciferolorder of treatments cholecalciferol, calcium and Cholecalciferol, placebo, and calcium
PlaceboCholecalciferolorder of interventions placebo,calcium, cholecalciferol, calcium plus cholecalciferol
PlaceboCalciumorder of interventions placebo,calcium, cholecalciferol, calcium plus cholecalciferol
PlaceboPlaceboorder of interventions placebo,calcium, cholecalciferol, calcium plus cholecalciferol
CalciumCalciumorder of treatment calcium, placebo, calcium plus cholecalciferol, cholecalciferol
CalciumPlaceboorder of treatment calcium, placebo, calcium plus cholecalciferol, cholecalciferol
Calcium and cholecalciferolCalciumorder of treatment calcium and cholecalciferol, cholecalciferol, calcium, placebo
Calcium and cholecalciferolCalcium and cholecalciferolorder of treatment calcium and cholecalciferol, cholecalciferol, calcium, placebo
PlaceboCalcium and cholecalciferolorder of interventions placebo,calcium, cholecalciferol, calcium plus cholecalciferol
Calcium and cholecalciferolCholecalciferolorder of treatment calcium and cholecalciferol, cholecalciferol, calcium, placebo
CholecalciferolPlaceboorder of treatments cholecalciferol, calcium and Cholecalciferol, placebo, and calcium
Primary Outcome Measures
NameTimeMethod
Percent true calcium absorptionAfter 6 months of treatment
Secondary Outcome Measures
NameTimeMethod
Bone Mineralization by Dual Energy x-ray absorptionAfter 6 months treatment plus 3 month washout

Trial Locations

Locations (1)

University of Missouri Hospitals and clinics

🇺🇸

Columbia, Missouri, United States

© Copyright 2025. All Rights Reserved by MedPath